NO20081045L - Forbindelser og fremgangsmater for behandling av cancer - Google Patents
Forbindelser og fremgangsmater for behandling av cancerInfo
- Publication number
- NO20081045L NO20081045L NO20081045A NO20081045A NO20081045L NO 20081045 L NO20081045 L NO 20081045L NO 20081045 A NO20081045 A NO 20081045A NO 20081045 A NO20081045 A NO 20081045A NO 20081045 L NO20081045 L NO 20081045L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methods
- treating cancer
- leukemia
- potent
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001495 arsenic compounds Chemical class 0.000 abstract 1
- 210000000601 blood cell Anatomy 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 229940093920 gynecological arsenic compound Drugs 0.000 abstract 1
- 230000002489 hematologic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/72—Aliphatic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70416305P | 2005-07-29 | 2005-07-29 | |
| PCT/US2006/029835 WO2007027344A2 (en) | 2005-07-29 | 2006-07-28 | Compounds and methods for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081045L true NO20081045L (no) | 2008-04-25 |
Family
ID=37809342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081045A NO20081045L (no) | 2005-07-29 | 2008-02-28 | Forbindelser og fremgangsmater for behandling av cancer |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7968738B2 (es) |
| EP (2) | EP2394702B1 (es) |
| JP (1) | JP4994374B2 (es) |
| AU (1) | AU2006285329B2 (es) |
| CA (1) | CA2617049A1 (es) |
| ES (2) | ES2532666T3 (es) |
| NO (1) | NO20081045L (es) |
| WO (1) | WO2007027344A2 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2532666T3 (es) | 2005-07-29 | 2015-03-30 | Solasia Pharma K.K. | Compuestos y métodos para el tratamiento del cáncer |
| TW200829261A (en) * | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| KR20100100835A (ko) * | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | 유기 비소제와의 병용 요법 |
| KR20100097679A (ko) * | 2007-12-12 | 2010-09-03 | 지오팜 온콜로지 인코포레이티드 | 암 치료 화합물 및 방법 |
| WO2010021928A1 (en) * | 2008-08-20 | 2010-02-25 | Ziopharm Oncology, Inc. | Organoarsenic compounds and methods for the treatment of cancer |
| ES2641847T3 (es) | 2012-09-20 | 2017-11-14 | Yogesh Narayan BENDALE | Proceso para biosintetizar nanotrióxido de arsénico y su uso en el tratamiento de enfermedades que incluyen el cáncer |
| WO2015085208A1 (en) * | 2013-12-05 | 2015-06-11 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| CA2978401C (en) * | 2015-03-12 | 2022-04-12 | The Chemo-Sero-Therapeutic Research Institute | Anti-adhesion material and substitute biomembrane using decellularized tissue |
| CN107167433A (zh) * | 2016-03-07 | 2017-09-15 | 天津国际生物医药联合研究院 | 一种检测氯二甲基砷的方法 |
| JPWO2019220961A1 (ja) * | 2018-05-18 | 2020-05-28 | ソレイジア・ファーマ株式会社 | ダリナパルシンのアルカリ金属塩及び／又は無機酸付加塩の結晶型及びその製剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| DK2018858T3 (da) * | 1997-10-15 | 2013-01-07 | Polarx Biopharmaceuticals Inc | Sammensætninger og fremgangsmåder til behandlingen af primære og metastatiske neoplastiske sygdomme ved anvendelse af arsentrioxid |
| BR9814857A (pt) * | 1997-11-10 | 2001-12-26 | Sloan Kettering Inst Cancer | Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril |
| WO1999029336A1 (en) * | 1997-12-05 | 1999-06-17 | Eli Lilly And Company | Glp-1 formulations |
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| SE9802080D0 (sv) * | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) * | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| ES2261399T3 (es) * | 2000-04-26 | 2006-11-16 | Oregon Health Sciences University | Administracion de un compuesto quimioprotector que contiene tiol. |
| EP2462932A1 (en) | 2002-01-07 | 2012-06-13 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TWI411431B (zh) * | 2004-07-16 | 2013-10-11 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| ES2532666T3 (es) | 2005-07-29 | 2015-03-30 | Solasia Pharma K.K. | Compuestos y métodos para el tratamiento del cáncer |
| KR20100100835A (ko) * | 2007-11-02 | 2010-09-15 | 지오팜 온콜로지 인코포레이티드 | 유기 비소제와의 병용 요법 |
-
2006
- 2006-07-28 ES ES11180330.0T patent/ES2532666T3/es active Active
- 2006-07-28 WO PCT/US2006/029835 patent/WO2007027344A2/en not_active Ceased
- 2006-07-28 EP EP11180330.0A patent/EP2394702B1/en not_active Not-in-force
- 2006-07-28 JP JP2008524273A patent/JP4994374B2/ja active Active
- 2006-07-28 ES ES06824793T patent/ES2531159T3/es active Active
- 2006-07-28 AU AU2006285329A patent/AU2006285329B2/en not_active Ceased
- 2006-07-28 EP EP06824793.1A patent/EP1919564B1/en active Active
- 2006-07-28 CA CA002617049A patent/CA2617049A1/en not_active Abandoned
- 2006-07-28 US US11/495,172 patent/US7968738B2/en active Active
-
2008
- 2008-02-28 NO NO20081045A patent/NO20081045L/no not_active Application Discontinuation
-
2011
- 2011-06-01 US US13/150,516 patent/US8334398B2/en active Active
-
2012
- 2012-11-14 US US13/676,929 patent/US8865764B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20070183972A1 (en) | 2007-08-09 |
| ES2531159T3 (es) | 2015-03-11 |
| WO2007027344A2 (en) | 2007-03-08 |
| JP4994374B2 (ja) | 2012-08-08 |
| HK1164767A1 (en) | 2012-09-28 |
| EP2394702B1 (en) | 2014-12-31 |
| EP2394702A1 (en) | 2011-12-14 |
| JP2009502971A (ja) | 2009-01-29 |
| US7968738B2 (en) | 2011-06-28 |
| US20130142730A1 (en) | 2013-06-06 |
| AU2006285329A1 (en) | 2007-03-08 |
| US8865764B2 (en) | 2014-10-21 |
| WO2007027344A3 (en) | 2007-12-21 |
| AU2006285329A2 (en) | 2008-08-14 |
| ES2532666T3 (es) | 2015-03-30 |
| EP1919564B1 (en) | 2014-11-26 |
| CA2617049A1 (en) | 2007-03-08 |
| HK1117780A1 (en) | 2009-01-23 |
| US8334398B2 (en) | 2012-12-18 |
| AU2006285329B2 (en) | 2012-10-04 |
| EP1919564A2 (en) | 2008-05-14 |
| US20120022229A1 (en) | 2012-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081045L (no) | Forbindelser og fremgangsmater for behandling av cancer | |
| TW200616615A (en) | Compounds and methods for the treatment of cancer | |
| WO2011098262A3 (en) | P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth | |
| SG151267A1 (en) | Carboline derivatives useful in the inhibition of angiogenesis | |
| NO20075918L (no) | Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav | |
| ECSP088536A (es) | DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR | |
| TW200740776A (en) | N-phenylbenzotriazolyl c-kit inhibitors | |
| NZ597075A (en) | 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer | |
| WO2006058014A3 (en) | Harnessing network biology to improve drug discovery | |
| MY139942A (en) | Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors | |
| RU2711869C3 (ru) | Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk | |
| WO2005113747A3 (de) | Multizelluläre gewebe- und organkultursysteme | |
| UY29826A1 (es) | Derivados de pirimidina, sales farmaceuticamente aceptables, esteres de los mismos hidrolisables in vivo, procesos de preparacion y aplicaciones | |
| BRPI0607306A2 (pt) | derivados de quinoxalina como agentes anti-tumor | |
| NL2000375A1 (nl) | Pyrimidinederivaten voor de behandeling van abnormale celgroei. | |
| MY146112A (en) | Long-term feed - cancer patient | |
| TNSN07369A1 (en) | Heteroaryl urea derivatives useful for inhibiting chki | |
| WO2006009765A3 (en) | Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells | |
| WO2010028373A3 (en) | Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients | |
| WO2007118751A3 (de) | Verfahren zur veränderung des atp-adp-verhältnisses in zellen | |
| IL186121A0 (en) | Substituted 1,5-naphthyridine azolidinones as cdk inhibitors | |
| EP4328319A3 (en) | Methods and compositions for identifying and treating patients with small cell lung cancer | |
| DE60004027D1 (de) | Organische-arsenverbindungen | |
| TW200731991A (en) | Lipophilic di(anticancer drug) compounds, compositions and related methods | |
| MY150745A (en) | Isoserine derivatives for use as coagulation factor ixa inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |